New sanctions · Sept 30, 2026 OFAC tightened the CACR: no U.S. bank accounts for Cuban entrepreneurs, U-turn ended, indirect Restricted List dealings barred, professional-meeting and people-to-people travel ended. Remittances (§515.570) and contractor and import payments (§515.582) unchanged; payments to suppliers outside the U.S. now prohibited.What changed, and how QvaPay keeps the lawful lanes open →

Permitted Fund Flows Every U.S.–Cuba fund flow, with its authority and standing — remittances, payments to independent Cuban contractors, donations, prepaid top-ups, assisted purchases from U.S. providers, buying from Cuban entrepreneurs, and exports from the United States — each shown with its license and its standing after the September 30 rule.See the flows →

QvaPay SentinelLive at sdn.qvapay.com — screen names, entities and crypto wallets against OFAC's SDN list, plus regime-linked sources Washington has never designated.Try Sentinel →

New on The WorldCuba Study Group's Ricardo Herrero on Cuba's reforms and U.S. investors positioning for an opening.Listen →

New CubaOpportunity Atlas

ES Donate SupportSupport Cuba's Private Sector

Not legal, tax or investment advice, and not authorization for any transaction. U.S. sanctions (31 CFR Part 515) prohibit investment or equity in any Cuban business; nothing here is a determination that a transaction is lawful. Structure anything Cuba-facing only with qualified OFAC sanctions counsel and screen every party with QvaPay Sentinel.

Primary sources: OFAC Cuba Sanctions · 31 CFR Part 515 (CACR) · OFAC Cuba FAQs · Cuba Restricted List

← All entities

BioCubaFarma

aka BioCubaFarma, CIGB

State — embargo-restricted

State biotech & pharma holding (CIGB, CIM). World-class IP; heavy sanctions sensitivity on any U.S. nexus.

Assets controlled

Sub-entity / settlement counterparty. Relevant to compliance screening rather than a specific mapped asset.

Sources: BioCubaFarma